Active ingredientZaleplonCat. No. P-Z003-001CAS 151319-34-5Family · Pharmaceutical analytical standards
Zaleplon
A non-benzodiazepine hypnotic with a pyrazolopyrimidine structure, approved in the United States in 1999 for insomnia, especially for people who struggle to fall asleep: it acts on the GABA-A receptor like the benzodiazepines, despite its different structure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Together with zolpidem and zopiclone it belongs to the so-called 'Z-drugs', named after the first letter of their names; its half-life, about one hour, is the shortest of the group.
Go to the active ingredient →Active ingredientZaleplonCat. No. P-Z003-001CAS 151319-34-5
Pharmacopoeial impurityZaleplon USP Related Compound ACat. No. P-Z003-002CAS 96605-66-2
Pharmacopoeial impurityZaleplon USP Related Compound BCat. No. P-Z003-003CAS 478081-98-0
Pharmacopoeial impurityZaleplon USP Related Compound CCat. No. P-Z003-004CAS 940951-54-2
Isotopically labelledZaleplon-d5Cat. No. P-Z003-005CAS 1001083-56-2
Impurity3'-AcetylformanilideCat. No. P-Z003-006CAS 72801-78-6
ImpurityZaleplon Impurity 1Cat. No. P-Z003-007CAS 1796965-05-3
ImpurityZaleplon Impurity 2Cat. No. P-Z003-008CAS 940951-59-7
ImpurityDesethylzaleplonCat. No. P-Z003-010CAS 115931-01-6
ImpurityZaleplon Impurity 3Cat. No. P-Z003-011CAS 115932-13-3
Impurityn-(3-Acetylphenyl)-n-ethylacetamideCat. No. P-Z003-012CAS 200630-96-2
ImpurityZaleplon Impurity 4Cat. No. P-Z003-013CAS 1227694-91-8
ImpurityZaleplon Impurity 5Cat. No. P-Z003-014CAS 1227694-93-0
ImpurityZaleplon Impurity 6Cat. No. P-Z003-015CAS 1227694-86-1
ImpurityZaleplon Impurity 7Cat. No. P-Z003-016
ImpurityZaleplon Impurity 8Cat. No. P-Z003-017CAS 2518277-07-9
ImpurityZaleplon Impurity 9Cat. No. P-Z003-018CAS 2517944-95-3
ImpurityZaleplon Impurity 10Cat. No. P-Z003-019
ImpurityZaleplon Oxopropenyl AnalogCat. No. P-Z003-020CAS 940951-61-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.